MyoD directly binds to F3 fragment through the E-box-like element EMSA analysis of MyoD binding to F3 fragment was performed with 32 P labelled oligonucleotides designed on fragment 3 and containing either wild type (F3) or mutated (mutated F3) E-box-like sequences. Nuclear extract prepared from differentiated C2 cells were analyzed for the binding to wild type or mutated sequences. Wild type or mutated competitor probes were added in a 100-fold molar excess. The specificity of binding was tested by means of anti-MyoD antibody. Arrows indicate the mobility of protein-DNA complexes (shift) and that of antibody-protein-DNA complexes (supershift). An oligonucleotide designed on MCK enhancer and containing a canonical E-box was used as positive control.
Supplementary Figure 3
MyoD induces H3 acetylation at F3 in responsive cells q-ChIP assays were performed to analyze H3 acetylation at F3 and myogenin (myog) promoter in responsive (C57BL) and unresponsive (C3H10T1/2) mouse embryo fibroblasts, infected with either a retroviral empty vector as a control (C) or with a retroviral vector expressing MyoD (M) and analyzed after 24 hours of differentiation. qPCR values, normalized relative to the input chromatin and to the Pancreatic amylase 2 (Amy2) signal, used as a baseline control, were expressed as fold increase respect to control cells.
The values reported in the graphs are representative of three independent experiments. The error bars indicate the standard deviation for each sample analyzed in triplicate. 
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